The Prognostic Role of Polysomnography Parameters in Heart Failure Patients with Previous Decompensation.

heart failure polysomnography prognosis sleep apnea wake after sleep onset

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
24 Jun 2022
Historique:
received: 18 05 2022
revised: 19 06 2022
accepted: 21 06 2022
entrez: 9 7 2022
pubmed: 10 7 2022
medline: 10 7 2022
Statut: epublish

Résumé

Background: Sleep-disordered breathing (SDB) is a widespread comorbidity in patients with chronic heart failure (HF) and may have a deleterious effect on the pathogenesis of HF. We aimed to evaluate the prognostic role of polysomnography parameters in HF patients with previous decompensation. Methods: 123 patients were included in the prospective cohort study. In addition to the standard examination, all patients underwent polysomnography (PSG). Results: The Kaplan−Meier analysis showed the incidence of the combined endpoint differs between LVEF categories ≤25.5% vs. >25.5% (χ2 = 9.6, log rank p = 0.002), NTpro-BNP > 680 vs. ≤680 pg/mL (χ2 = 12.7, log rank p = 0.001), VO2peak categories <16 vs. ≥16 mL/min/kg (χ2 = 14.2, log rank p = 0.001), VE/VCO2 slope ≥38.5 vs. <38.5 (χ2 = 14.5, log rank p = 0.001), wake after sleep onset >40 min vs. ≤40 min (χ2 = 9.7, log rank p = 0.03), and sleep stage 2 (S2) <44% vs. ≥44% (χ2 = 12.4, log rank p = 0.001). Conclusion: Among the PSG parameters, WASO > 40 min and S2 < 44% were associated with a combined endpoint in patients with previous decompensation of HF. Moreover, higher NT-proBNP and VE/VCO2 slope, lower LVEF, and VO2peak were also independent factors of a poor prognosis.

Identifiants

pubmed: 35806941
pii: jcm11133656
doi: 10.3390/jcm11133656
pmc: PMC9267942
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : the Ministry of Science and Higher Education of the Russian Federation
ID : Agreement No. 075-15-2022-301

Références

Clin Cardiol. 2020 Apr;43(4):329-337
pubmed: 31967668
Eur Respir J. 2013 Jun;41(6):1340-6
pubmed: 23018907
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
Eur Heart J. 2015 Jun 14;36(23):1463-9
pubmed: 25636743
J Am Heart Assoc. 2021 Apr 6;10(7):e016201
pubmed: 33719504
Laryngoscope. 2014 Jan;124(1):337-43
pubmed: 23794206
Circulation. 2010 Jul 27;122(4):352-60
pubmed: 20625114
J Card Fail. 2015 Feb;21(2):126-33
pubmed: 25451705
Clin Med Insights Cardiol. 2018 Dec 04;12:1179546818809358
pubmed: 30618487
Int J Cardiol. 2016 Jan 15;203:1022-8
pubmed: 26630630
Eur Heart J. 2011 Jan;32(1):61-74
pubmed: 20846992
Nat Rev Cardiol. 2016 Jul;13(7):389-403
pubmed: 27173772
Eur Heart J Cardiovasc Imaging. 2017 Dec 01;18(12):1301-1310
pubmed: 29045589
Sleep. 1999 Aug 1;22(5):667-89
pubmed: 10450601
Chest. 2007 Mar;131(3):733-739
pubmed: 17356087

Auteurs

Elena Medvedeva (E)

Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.

Lyudmila Korostovtseva (L)

Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.

Mihail Bochkarev (M)

Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.

Anastasiya Shumeiko (A)

Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.

Aelita Berezina (A)

Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.

Maria Simonenko (M)

Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.

Yulia Sazonova (Y)

Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.

Andrey Kozlenok (A)

Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.

Yurii Sviryaev (Y)

Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.

Classifications MeSH